Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2023-08-01 00:00:00 ET · period of report 2022-12-06 · accession 0000897069-23-001044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2023-08-01 | 2022-12-06+ | CNSP | Priebe Waldemar | 10% | S - Sale | $1.41 | -94.3K | 166.8K | -36% | -$133.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-28 | S | D | 10,000 | $1.04 | 156,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 2 | Common | Common Stock | 2022-12-06 | S | D | 5,500 | $2.47 | 245,605 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 3 | Common | Common Stock | 2022-12-07 | S | D | 5,500 | $2.46 | 240,105 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 4 | Common | Common Stock | 2022-12-08 | S | D | 5,500 | $2.40 | 234,605 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 5 | Common | Common Stock | 2022-12-09 | S | D | 2,798 | $2.43 | 231,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 6 | Common | Common Stock | 2023-03-10 | S | D | 5,000 | $1.29 | 226,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 7 | Common | Common Stock | 2023-03-13 | S | D | 5,000 | $1.30 | 221,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 8 | Common | Common Stock | 2023-03-14 | S | D | 5,000 | $1.35 | 216,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 9 | Common | Common Stock | 2023-03-15 | S | D | 5,000 | $1.22 | 211,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 10 | Common | Common Stock | 2023-03-16 | S | D | 5,000 | $1.24 | 206,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 11 | Common | Common Stock | 2023-03-17 | S | D | 5,000 | $1.13 | 201,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 12 | Common | Common Stock | 2023-03-20 | S | D | 5,000 | $1.08 | 196,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 13 | Common | Common Stock | 2023-03-21 | S | D | 5,000 | $1.10 | 191,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 14 | Common | Common Stock | 2023-03-22 | S | D | 5,000 | $1.08 | 186,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 15 | Common | Common Stock | 2023-03-23 | S | D | 10,000 | $1.08 | 176,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 16 | Common | Common Stock | 2023-03-24 | S | D | 5,000 | $1.08 | 171,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |
| 17 | Common | Common Stock | 2023-03-27 | S | D | 5,000 | $1.09 | 166,807 | I See footnote | — | — | (F1) Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |